You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BLTE Sale Disclosure
Scholl Hendrik Peter · SEC Form 4 · Filed Oct 5, 2026
Sale
Calculated transaction value
$8.32K
Scholl Hendrik Peter Chief Medical Officer
BLTE
Belite Bio, Inc
BLTE
Transaction date
Oct 1, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 4 days later
BLTE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- American depositary share
- Quantity / price
- 50 shares @ $166.44
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-414643
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$82.66K
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Belite Bio, Inc BLTE | Sale | Oct 1, 2026 | $13.07K |
| Belite Bio, Inc BLTE | Sale | Oct 1, 2026 | $2.02K |
| Belite Bio, Inc BLTE | Sale | Oct 1, 2026 | $2.37K |
| Belite Bio, Inc BLTE | Sale | Oct 1, 2026 | $340.04 |
| Belite Bio, Inc BLTE | Sale | Oct 1, 2026 | $32.73K |
| Belite Bio, Inc BLTE | Sale | Oct 1, 2026 | $19.86K |
| Belite Bio, Inc BLTE Current | Sale | Oct 1, 2026 | $8.32K |
| Belite Bio, Inc BLTE | Sale | Oct 1, 2026 | $3.95K |